Retrospective Analysis Of Comparative Outcomes In Recurrent Platinum-Sensitive Ovarian Cancer Treated With Pegylated Liposomal Doxorubicin (Lipo-Dox) And Carboplatin Versus Paclitaxel And Carboplatin

Overview of attention for article published in Cancer Management and Research, November 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

Recurrent ovarian cancer in Africa: Rate and associated factors at a gynecologic oncology treatment center in Ethiopia—A cross‐sectional study

Article in International Journal of Gynecology & Obstetrics (December 2023)

Real-World Efficacy of Bevacizumab in Patients With Recurrent Epithelial Ovarian Cancer

Article in Frontiers in Oncology (May 2022)

Mechanomimetic 3D Scaffolds as a Humanized In Vitro Model for Ovarian Cancer

Article in Cells (February 2022)